Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Biological Effects of Quercetin in COPD Phase II (polyphenols)

view all Clinical Trials

Overview

This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.

Clinical Trial Information

Protocol

TIRB# 25738

Phase

2

Condition(s)

Chronic Obstructive Pulmonary Disease (COPD)

Investigator

Nathaniel Marchetti, DO

Coordinator

Sara Khademolhosseini

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II